Hughes D C, Fischer A B, O'Brien P Q. "Method for the Synthesis of Methyl 4-cyclopropyl-3-oxo-2,3,4,5-tetrahydrobenzo[f][1,4]oxazepine-7-carboxylate" [P]. US Patent, US 11846276 B2, 2018-03-21.
发明人韩伟,沈红梅,李文辉. "A Process for Preparing High-Purity Methyl 4-cyclopropyl-3-oxo-2,3,4,5-tetrahydrobenzo[f][1,4]oxazepine-7-carboxylate" [P]. 中国发明专利, 专利号 CN 108824282 A, 授权公告日 2018-11-22.
参考文献 Literature
Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2021, 2120, (10), 7264-7270.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chim. Acta, 2014, 1941, 1318-1324.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of Methyl 4-cyclopropyl-3-oxo-2,3,4,5-tetrahydrobenzo[f][1,4]oxazepine-7-carboxylate Using HRMS and NMR". Environ. Sci. Technol., 2014, 304, 9452-9458.
Zhang Y, Li Q, Chen T. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2022, 2214, (1), 5819-5842.